Articles

Masitinib on muscles

Compound may protect muscles and nerves in amyotrophic lateral sclerosis sufferers
Written byIlene Schneider
| 3 min read

PARIS—Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a rare degenerative disorder that results in progressive wasting and paralysis of voluntary muscles. There are approximately 50,000 people with ALS in the European Union and in the United States, with more than 16,000 new cases diagnosed each year. Almost 80 percent of ALS patients die within five years, and 90 percent die within 10 years.

AB Science SA, a pharmaceutical company specializing in the research, development and marketing of protein kinase inhibitors (PKIs), thinks it has an answer. The company announced that new mechanistic data demonstrate the unexpected protective effect of its compound, masitinib, on muscles and nerves in ALS.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.